Prosecution Insights
Last updated: May 29, 2026
Application No. 18/978,623

METHODS AND COMPOSITIONS FOR MAGNETIZABLE PLASTICS

Final Rejection §103
Filed
Dec 12, 2024
Priority
Jul 25, 2017 — provisional 62/536,536 +4 more
Examiner
YOUNG, WILLIAM D
Art Unit
1761
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Magnomer Inc.
OA Round
2 (Final)
54%
Grant Probability
Moderate
3-4
OA Rounds
1y 6m
Est. Remaining
70%
With Interview

Examiner Intelligence

Grants 54% of resolved cases
54%
Career Allowance Rate
371 granted / 688 resolved
-11.1% vs TC avg
Strong +16% interview lift
Without
With
+16.2%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
32 currently pending
Career history
732
Total Applications
across all art units

Statute-Specific Performance

§103
78.9%
+38.9% vs TC avg
§102
12.3%
-27.7% vs TC avg
§112
8.0%
-32.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 688 resolved cases

Office Action

§103
DETAILED ACTION The following Office action concerns Patent Application Number 18/978,623. Claims 55, 58-62, 64-71, 75-78, 80, 84, 85, 89, 91-93 are pending in the application. Claims 58-62 and 64-69 have been withdrawn from consideration as being drawn to non-elected inventions. The applicant’s amendment filed October 28, 2025 has been entered. Election/Restrictions A restriction requirement was sent to the Applicant on July 28, 2025. The Applicant was required to elect among several groups of inventions. The Applicant responded to the restriction requirement on October 28, 2025 and elected Group VI, claim 93 plus linking claims, without traverse. Accordingly, claims 58-62 and 64-69 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to non-elected inventions. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. § 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 55, 70, 71, 75-78, 80, 84, 85, 89, 91-93 are rejected under 35 U.S.C. § 103 as being unpatentable over Sperry (US 3,409,129) in view of Iftime et al (US 2012/0235074) and Loccufier et al (US 2016/0200923). Sperry teaches a plastic bottle having a film attached to the surface (col. 4, lines 15-20). The film contains a magnetic ink (col. 4, lines 30-45; Fig. 5). The magnetic ink is ferromagnetic as that term is described in the instant specification. The film is used as a label for a pharmaceutical container (col. 1, lines 32-40). Sperry does not teach the composition of the magnetic ink. However, Iftime et al teaches a magnetic ink comprising magnetic particles and polymer resins (par. 9, 74). The ink is used to print magnetic characters on a substrate (par. 4). The magnetic particles are ferromagnetic (par. 61). The magnetic particles include an alloy of iron and cobalt (par. 64). A person of ordinary skill in the art would have been motivated by design need to combine the ink composition of Iftime et al with the magnetic ink of Sperry in view of Loccufier et al in order to obtain an ink useful for printing magnetic characters on a substrate or film. Sperry does not teach the migration rate of the ink. However, Loccufier et al teaches a printing ink which is a food or pharmaceutical contact substance and which has a migration rate of less than 10 µg/6 dm2 to comply with the majority of government regulations (par. 6, 196). 10 µg/6 dm2 is equivalent to about 0.0017 mg/dm2. Since the ink of Sperry is used for pharmaceutical packaging and Loccufier et al teaches a migration rate for pharmaceutical packaging, a person of ordinary skill in the art would have been motivated to combine the migration rate of Loccufier et al with the ink of Sperry in view of Iftime et al in order to comply with government safety regulations. Regarding claims 70 and 71, the amount of ink applied to the label on the bottle and the size of the bottle would have been obvious to a person of ordinary skill in the art in view of the references. The references teach the same ink composition and the same use as the invention. The optimum amount of ink and optimum bottle size would have been determined by routine experimentation. Furthermore, the claimed amount of ink and bottle size are well known in the art (see Shafe et al, col. 4, lines 48-54). MPEP 2144.05(II). Regarding claim 80, Iftime et al teaches that the resins include acrylic resin (par. 74). Regarding claims 84, 85, 89, Iftime et al teaches an amount of magnetic particles of 0.5-30 wt % and an amount of resin of 0.1-10 wt % (par. 68, 77). The resulting weight ratio of magnetic material to resin includes 30/10 or 3/1. The ink is temporarily magnetized by an applied magnetic field (par. 62). Regarding claim 91, Sperry teaches that the ink comprises at least one layer (col. 4, lines 30-45). Regarding claim 93, Iftime et al teaches that the ink further comprises a colorant (par. 9). Examiner’s Information Any inquiry concerning this communication or earlier communications from the examiner should be directed to William Young whose telephone number is (571) 270-5078. The examiner can normally be reached Monday through Friday, 8:30 AM to 5 PM. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Angela Brown-Pettigrew, can be reached at 571-272-2817. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000./WILLIAM D YOUNG/Primary Examiner, Art Unit 1761 January 6, 2026
Read full office action

Prosecution Timeline

Dec 12, 2024
Application Filed
Jan 12, 2026
Non-Final Rejection mailed — §103
May 08, 2026
Response Filed
May 27, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12637479
LOW ENERGY GAP SMALL MOLECULE MATERIAL AND ORGANIC OPTOELECTRONIC DEVICE USING THE SAME
3y 10m to grant Granted May 26, 2026
Patent 12637392
ELECTRICALLY-CONDUCTIVE ASPHALT CONCRETE CONTAINING CARBON FIBERS
1y 4m to grant Granted May 26, 2026
Patent 12626835
CONDUCTIVE SILVER ALUMINUM PASTE, METHOD FOR PREPARING THE SAME, AND ELECTRODE USING THE SAME
2y 10m to grant Granted May 12, 2026
Patent 12628321
ELECTROMAGNETIC ABSORBING COMPOSITES
2y 11m to grant Granted May 12, 2026
Patent 12612502
ADHESIVE TREATMENT LIQUID, AND METHOD FOR TREATING ADHESIVE
3y 4m to grant Granted Apr 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
54%
Grant Probability
70%
With Interview (+16.2%)
2y 11m (~1y 6m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 688 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month